April 8, 2026· The Peptide SignalPREMIUM

Retatrutide: 28.7% Weight Loss and What the TRIUMPH Data Means

ResearchWeight LossGLP-1

TRIUMPH-4 Phase 3: 28.7% weight loss at 68 weeks. The largest ever in a Phase 3 obesity trial. Seven more readouts coming in 2026.

🔒

Premium Post

This post is available to premium subscribers. Subscribe to access the full article and all premium content.

For research and educational purposes only · Not medical advice · Consult a qualified physician before any human use